CoChat
Sign Up
Cited by 31

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

APP processing and metabolism in corneal fibroblasts and epithelium as a potential biomarker for Alzheimer's disease

Choi, Seung-il, Lee, Boram, Woo, Jong Hwan, Jeong, Jang Bin, Jun, Ikhyun, Kim, Eung Kweon·2019·Experimental Eye Research
DOI 10.1016/j.exer.2019.03.012
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.exer.2019.03.012

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Research works printed but not linked: 55

  1. Alberto, 2013, Corneal sublayers thickness estimation obtained by high-resolution FD-OCT, Int. J. Biomed. Imaging, 2013, 989624, 10.1155/2013/989624 · DOI
  2. Annaert, 2002, A cell biological perspective on Alzheimer's disease, Annu. Rev. Cell Dev. Biol., 18, 25, 10.1146/annurev.cellbio.18.020402.142302 · DOI · Paper page
  3. Checler, 1995, Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease, J. Neurochem., 65, 1431, 10.1046/j.1471-4159.1995.65041431.x · DOI · Paper page
  4. Choi, 2016, TGF-beta regulates TGFBIp expression in corneal fibroblasts via miR-21, miR-181a, and Smad signaling, Biochem. Biophys. Res. Commun., 472, 150, 10.1016/j.bbrc.2016.02.086 · DOI
  5. Choi, 2012, Impaired autophagy and delayed autophagic clearance of transforming growth factor beta-induced protein (TGFBI) in granular corneal dystrophy type 2, Autophagy, 8, 1782, 10.4161/auto.22067 · DOI
  6. Choi, 2009, Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II, Am. J. Pathol., 175, 248, 10.2353/ajpath.2009.081001 · DOI
  7. Choi, 2014, Autophagy is induced by raptor degradation via the ubiquitin/proteasome system in granular corneal dystrophy type 2, Biochem. Biophys. Res. Commun., 450, 1505, 10.1016/j.bbrc.2014.07.035 · DOI
  8. Choi, 2015, Lysosomal trafficking of TGFBIp via caveolae-mediated endocytosis, PLoS One, 10
  9. Di Luca, 1998, Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease, Arch. Neurol., 55, 1195, 10.1001/archneur.55.9.1195 · DOI
  10. Donev, 2007, A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms, Mol. Psychiatr., 12, 681, 10.1038/sj.mp.4001971 · DOI
  11. Dutescu, 2009, Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease, Graef Arch. Clin. Exp., 247, 1213, 10.1007/s00417-009-1060-3 · DOI
  12. Friedman, 2009, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res., 19, 92, 10.1101/gr.082701.108 · DOI · Paper page
  13. Frost, 2010, Ocular biomarkers for early detection of Alzheimer's disease, J. Alzheimer's Dis., 22, 1, 10.3233/JAD-2010-100819 · DOI
  14. Garcia, 2016, Differential expression of proteoglycans by corneal stromal cells in keratoconus, Investig. Ophthalmol. Vis. Sci., 57, 2618, 10.1167/iovs.15-16692 · DOI
  15. Golde, 1990, Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR, Neuron, 4, 253, 10.1016/0896-6273(90)90100-T · DOI
  16. Goldstein, 2001, A beta peptides in human and amyloid-bearing transgenic mouse lens: implications for Alzheimer's disease and cataracts, Investig. Ophthalmol. Vis. Sci., 42
  17. Goldstein, 2003, Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease, Lancet, 361, 1258, 10.1016/S0140-6736(03)12981-9 · DOI
  18. Hassell, 2010, The molecular basis of corneal transparency, Exp. Eye Res., 91, 326, 10.1016/j.exer.2010.06.021 · DOI · Paper page
  19. Hassell, 2008, Increased stromal extracellular matrix synthesis and assembly by insulin activated bovine keratocytes cultured under agarose, Exp. Eye Res., 87, 604, 10.1016/j.exer.2008.09.010 · DOI
  20. He, 2008, Epidermal growth factor synergism with TGF-beta1 via PI-3 kinase activity in corneal keratocyte differentiation, Investig. Ophthalmol. Vis. Sci., 49, 2936, 10.1167/iovs.07-0900 · DOI
  21. Iseri, 2006, Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease, J. Neuro Ophthalmol., 26, 18, 10.1097/01.wno.0000204645.56873.26 · DOI
  22. Jack, 2010, Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, Lancet Neurol., 9, 119, 10.1016/S1474-4422(09)70299-6 · DOI · Paper page
  23. Jester, 1996, Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes, Cornea, 15, 505, 10.1097/00003226-199609000-00011 · DOI
  24. Jester, 1999, Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly, Investig. Ophthalmol. Vis. Sci., 40, 1959
  25. Jester, 2003, Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts, Investig. Ophthalmol. Vis. Sci., 44, 1850, 10.1167/iovs.02-0973 · DOI
  26. Johnson, 1990, Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease, Science, 248, 854, 10.1126/science.2111579 · DOI
  27. Jun, 2012, Delta-catenin is genetically and biologically associated with cortical cataract and future alzheimer-related structural and functional brain changes, PLoS One, 7, 10.1371/journal.pone.0043728 · DOI
  28. Kang, 2010, Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer, Gynecol. Oncol., 118, 58, 10.1016/j.ygyno.2010.03.025 · DOI
  29. Keenan, 2015, Associations between primary open angle glaucoma, Alzheimer's disease and vascular dementia: record linkage study, Br. J. Ophthalmol., 99, 524, 10.1136/bjophthalmol-2014-305863 · DOI
  30. Kerbage, 2013, Alzheimer's disease diagnosis by detecting exogenous fluorescent signal of ligand bound to beta amyloid in the lens of human eye: an exploratory study, Front. Neurol., 4, 10.3389/fneur.2013.00062 · DOI
  31. Koh, 2005, BACE is degraded via the lysosomal pathway, J. Biol. Chem., 280, 32499, 10.1074/jbc.M506199200 · DOI
  32. McCubbin, 1988, Circular-dichroism studies on two murine serum amyloid A proteins, Biochem. J., 256, 775, 10.1042/bj2560775 · DOI
  33. Meehan, 2004, Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation, J. Biol. Chem., 279, 3413, 10.1074/jbc.M308203200 · DOI
  34. Mohan, 2003, Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK, Exp. Eye Res., 76, 71, 10.1016/S0014-4835(02)00251-8 · DOI
  35. Moncaster, 2010, Alzheimer's disease amyloid-beta links lens and brain pathology in down syndrome, PLoS One, 5, 10.1371/journal.pone.0010659 · DOI
  36. Norling, 1988, Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosis, Clin. Exp. Immunol., 73, 333
  37. Passer, 2000, Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor, J. Alzheimer's Dis., 2, 289, 10.3233/JAD-2000-23-408 · DOI
  38. Proitsi, 2012, Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation, Neurobiol. Aging, 33, 10.1016/j.neurobiolaging.2011.12.036 · DOI
  39. Rockenstein, 1995, Levels and alternative splicing of amyloid-beta protein-precursor (app) transcripts in brains of app transgenic mice and humans with alzheimers-disease, J. Biol. Chem., 270, 28257, 10.1074/jbc.270.47.28257 · DOI
  40. Schipper, 2007, MicroRNA expression in Alzheimer blood mononuclear cells, Gene Regul. Syst. Biol., 1, 263
  41. Schonrock, 2012, Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta, J. Mol. Neurosci.: MN, 46, 324, 10.1007/s12031-011-9587-2 · DOI
  42. Selbach, 2008, Widespread changes in protein synthesis induced by microRNAs, Nature, 455, 58, 10.1038/nature07228 · DOI · Paper page
  43. Selkoe, 1998, The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease, Trends Cell Biol., 8, 447, 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
  44. Snow, 1989, Sulfated glycosaminoglycans in amyloid plaques of prion diseases, Acta Neuropathol., 77, 337, 10.1007/BF00687367 · DOI
  45. Snow, 1990, Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie, Lab. Invest., 63, 601
  46. Snow, 1987, A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils, Lab. Invest., 57, 687
  47. Snow, 1987, Sulfated glycosaminoglycans: a common constituent of all amyloids?, Lab. Invest., 56, 120
  48. Snow, 1987, Sulfated glycosaminoglycans in Alzheimer's disease, Hum. Pathol., 18, 506, 10.1016/S0046-8177(87)80036-9 · DOI
  49. Tanaka, 1989, Tissue-specific expression of three types of beta-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brain, Biochem. Biophys. Res. Commun., 165, 1406, 10.1016/0006-291X(89)92760-5 · DOI
  50. Tsolaki, 2011, Alzheimer's disease and primary open-angle glaucoma: is there a connection?, Clin. Ophthalmol., 5, 887, 10.2147/OPTH.S22485 · DOI
  51. Tuddenham, 2006, The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells, FEBS Lett., 580, 4214, 10.1016/j.febslet.2006.06.080 · DOI · Paper page
  52. Wang, 2014, Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival, Int. J. Clin. Exp. Pathol., 7, 2209
  53. Weber, 2010, The microRNA spectrum in 12 body fluids, Clin. Chem., 56, 1733, 10.1373/clinchem.2010.147405 · DOI · Paper page
  54. Yam, 2012, In vitro amyloid aggregate forming ability of TGFBI mutants that cause corneal dystrophies, Investig. Ophthalmol. Vis. Sci., 53, 5890, 10.1167/iovs.11-9068 · DOI
  55. Young, 1989, The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis, Acta Neuropathol., 78, 202, 10.1007/BF00688210 · DOI

Cited by

Sorted by citations

Metadata

Authors
Choi, S.-I., Lee, B., Woo, J. H., Jeong, J. B., Jun, I., & Kim, E. K.
Venue
Experimental Eye Research
Publisher
Elsevier BV
Published
2019-05
Volume
182
Pages
167-174
ISSN
0014-4835
DOI
10.1016/j.exer.2019.03.012
Cited by
31
References
4
Language
en
Licence
Funders
  • Ministry of Education (NRF-2016R1D1A1B03934794)
  • National Research Foundation of Korea
  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare (HI16C1009)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review